Navigation Links
Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
Date:12/13/2007

uticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the continuation of the Phase 3 program and development of lorcaserin, the significance of the inclusion in the BLOSSOM and BLOOM-DM trials of patients with FDA-defined valvulopathy and, in the case of the BLOOM-DM trial, with type 2 diabetes, the significance of the review of echocardiographic data, the timing of the Echocardiographic Safety Monitoring Board's month 12 review of echocardiographic data, the rate of valvulopathy in the BLOOM trial, the number of patients in the Phase 3 lorcaserin clinical trials, the timing, number, protocol, design, scope, cost and other aspects of the lorcaserin trials and studies, the completeness and usefulness of the expected database of lorcaserin data in exploring, evaluating and understanding lorcaserin, the growth and impact of obesity, the need for new treatment options to address obesity, the ability of lorcaserin to fulfill such need, the ability of data to support the use of lorcaserin, the tolerability, side effects, efficacy and the commercial and other potential of lorcaserin, the breadth of Arena's pipeline, Arena's strategy, preclinical and internal and partnered clinical programs, and about Arena's ability to develop compounds and commercialize drugs and other statements that are not historical facts. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, Arena's planned clinical trials and studies may not proceed at t
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
11. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... CA (PRWEB) April 23, 2015 Athena ... personal development of executive women in San Diego’s technology ... the 17th Annual Pinnacle Awards at their Gala on ... Hyatt Hotel. Register now at http://athenasd.org/events/ , ... support the Athena San Diego vision of fostering networking, ...
(Date:4/23/2015)... /CNW/ - A new and innovative service has won ... North America,s largest packaging trade association. ... the "Sustainability, service" category of the PAC Global ... is a service that scores clients, packaging against ... This benchmarking process shows clients how their packaging ...
(Date:4/23/2015)... (PRWEB) April 23, 2015 Six ... region on April 4-17 as part of the ... the fourth group of biotechnology startups to participate ... Nizhny Novgorod (UNN) and the University of Maryland ... ties between their respective universities in the biomedical ...
(Date:4/23/2015)... , April 23, 2015 WuXi PharmaTech (Cayman) ... capability and technology platform company serving the pharmaceutical, biotechnology ... China and the United States ... results for the first quarter of 2015 after the ... 2015 (which will be Thursday morning, May 14, 2015 ...
Breaking Biology Technology:Athena Pinnacle Awards to Honor Executives, Corporations and Educators Working to Promote Women Leaders 2U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 2U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 3U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 4WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release 2WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release 3
... and Addressing the ... Facing Clinical Labs Worldwide, ABBOTT PARK, Ill., April 4, ... of an initiative to,raise international awareness of the role played ... to improve,patient outcomes. Through a program called Labs Are Vital(TM), ...
... April 3, 2008 /Xinhua-PRNewswire-FirstCall/ --,Pharmaxis Ltd (ASX: PXS; ... trial in children with cystic fibrosis demonstrated excellent ... that,matched that achieved by the current marketed product ... on Bronchitol reflects that,seen in a previous study ...
... Inc. (Amex: ANX ) announced today that ... Directors, has joined the Company as,Executive Vice President, ... Executive Vice President, Mr. Bagnall will work with ... the Company,s,long-term strategy, help oversee internal execution of ...
Cached Biology Technology:International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative 2International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative 3Cystic Fibrosis Trial In Children Returns Positive Data 2Cystic Fibrosis Trial In Children Returns Positive Data 3Cystic Fibrosis Trial In Children Returns Positive Data 4ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer 2ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer 3ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer 4
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... for the 2015 New York Design Awards under the ... New York City Design Awards are part of a ... over 2,500 ratings from the marketplace, industry and judging ...
(Date:4/9/2015)... JOSE, Calif. , April 9, 2015 ... human interface solutions, announced today that it will report ... on Thursday, April 23, 2015, after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
(Date:4/2/2015)... April 2, 2015 At its 2015 ACMG ... City , the American College of Medical Genetics ... directors to its Board.  Members of the ACMG Board ... for forming and advancing its policies and programs. ACMG ... "It,s an eventful time in medical genetics ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... hospitals can collaborate on a surgery without having to ... in remote locations could receive immediate expert support from ... environment could soon become a reality thanks to research ... broadcast of surgeries using the advanced networking consortium Internet2. ...
... 2008─Bronx, NY─ In a breakthrough study appearing in advance ... Albert Einstein College of Medicine of Yeshiva University describe ... breast cancer cells for several days at a time. ... Center, provides detail on how cancer cells invade surrounding ...
... DURHAM, N.C. -- A new study led by Duke ... those that had been converted into farm fields -- ... that,s a good thing, say the study,s authors, because ... conditions. "It sounds counter-intuitive, but our study shows ...
Cached Biology News:The next step in health care: Telemedicine 2Einstein researchers develop a new way to study how breast cancer spreads 2Einstein researchers develop a new way to study how breast cancer spreads 3Shifts in soil bacterial populations linked to wetland restoration success 2Shifts in soil bacterial populations linked to wetland restoration success 3
... flexible and easy to use ... control all members of the ... features a clear and easy-to-follow ... setup, user-friendly and highly sophisticated ...
Strip Removal Tool 25/Box...
The bench-top stand comfortably holds up to 6 Finnpipette Digital single- and multichannel pipettes. The crossbars are made of a grippy material to keep the pipettes firmly in place. Individual shelf...
... Analysis Note: Protein determined by Biuret Physical ... mM Tris-HCl, pH 7.6, 1 mM MgCl ... Preparation Unit Definition: One unit will ... minute at pH 9.8 at 37 C. ...
Biology Products: